
PredictMe
PredictMe delivers precision health through AI-powered epigenetic analysis, enabling early detection of biological changes before symptoms appear. Its flagship product, PredictMe Delta, is an at-home finger-prick test that decodes DNA methylation patterns across 150,000+ reference samples to provide explainable insights into biological aging, cardiovascular, lung, and metabolic health.
- Healthcare Technology
- Biotechnology
- Artificial Intelligence
- Digital Health
- Data & Analytics
- Medical Devices
- Hardware
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Many chronic diseases begin developing years before symptoms appear, yet standard medical testing often only detects them after damage is done. Traditional diagnostic approaches fail to capture how lifestyle and environmental factors are shaping an individual's biology in real-time, leaving people without actionable insight into their health trajectory.
Solution
PredictMe delivers precision health through AI-powered epigenetic analysis that identifies early biological changes before symptoms manifest. The company's flagship product, PredictMe Delta, is a finger-prick test that reveals how lifestyle and environment are shaping an individual's biology at the molecular level. By decoding DNA methylation patterns across more than 150,000 reference samples, the platform's multi-model AI architecture generates explainable insights into biological aging, cardiovascular health, lung health, and metabolic status. This approach shifts healthcare from reactive treatment to proactive prevention, enabling individuals to detect changes earlier and make more informed decisions about their long-term wellbeing.
Target Audience
Primary customers include individuals seeking proactive health insights, and researchers and academic groups conducting epigenetic studies who need access to pretrained models and analysis pipelines for large cohort datasets.
Features
- Finger-prick sampling for convenient at-home or clinic-based epigenetic testing
- Multi-model AI architecture analyzing over 850,000 CpG sites for comprehensive biological insight
- Four pretrained explainable models covering biological age, cardiovascular health, lung health, and metabolic health
- Research pipeline processing raw DNA methylation data from Illumina arrays and Twist Human Methylome into publication-ready figures
- Explainable AI by design, tracing every prediction back to specific CpG sites and biological processes
- Custom data feeds, analytical reports, and licensed model access for research partnerships